Johnatty, Beesley, Chen, Macgregor, Duffy, Spurdle, deFazio, Gava, Webb, Rossing, Doherty, Goodman, Lurie, Thompson, Wilkens, Ness, Moysich, Chang-Claude, Wang-Gohrke, Cramer, Terry, Hankinson, Tworoger, Garcia-Closas, Yang, Lissowska, Chanock, Pharoah, S: "Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot"." in: PLoS genetics, Vol. 6, Issue 7, pp. e1001016, 2010 (PubMed).
Nagel, Venturini, Marquez, Meyer, Kaufmann, Scherr, MacLeod, Drexler: "Polycomb repressor complex 2 regulates HOXA9 and HOXA10, activating ID2 in NK/T-cell lines." in: Molecular cancer, Vol. 9, pp. 151, 2010 (PubMed).
Schotte, Dontje, Nagasawa, Yasuda, Bakker, Spits, Blom: "Synergy between IL-15 and Id2 promotes the expansion of human NK progenitor cells, which can be counteracted by the E protein HEB required to drive T cell development." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 184, Issue 12, pp. 6670-9, 2010 (PubMed).
Coma, Amin, Shimizu, Lasorella, Iavarone, Klagsbrun: "Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3F." in: Cancer research, Vol. 70, Issue 9, pp. 3823-32, 2010 (PubMed).
Kurowska-Stolarska, Distler, Jüngel, Rudnicka, Neumann, Pap, Wenger, Michel, Müller-Ladner, Gay, Maslinski, Gay, Distler: "Inhibitor of DNA binding/differentiation 2 induced by hypoxia promotes synovial fibroblast-dependent osteoclastogenesis." in: Arthritis and rheumatism, Vol. 60, Issue 12, pp. 3663-75, 2009 (PubMed).